林艳萍
强生集团杨森制药 代谢组学科学家
Dr. Lin obtained her PhD from the University of Tianjin (China) in 2009. After graduation, she worked in Dr. Bruce Hammock’s lab in University of California, Davis and Dr. Benjamin Garcia’s lab in University of Pennsylvania as an independent postdoctoral researcher conducting metabolomic research and services. In 2017, Dr. Lin joined Janssen as a metabolomics scientist. She has over 10 years of bioanalysis experience using gas/liquid chromatography coupled with Mass Spectrometry for various qualitative or quantitative research purposes. Developed, managed, and maintained several research projects involving the metabolomics and proteomics to serve for various pharmaceutical purposes including new drug candidates ADME, screening toxins, and biomarkers identifications/quantifications.
Dr. Lin has published dozens of papers and is currently working to explore the various applications of metabolomics in pharmaceutical research.